Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V
Clinical trial NCT01229397 · COMPLETED
Trial details
- NCT number
- NCT01229397
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2010-11-01
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.